期刊文献+

PTEN对乳腺癌多药耐药MCF-7/ADR细胞凋亡的促进作用及机制 被引量:1

Enhancement effect and mechanism of PTEN on apoptosis induced by adrimycin in breast cancer MCF-7/ADR cell
下载PDF
导出
摘要 目的观察野生型PTEN基因促进乳腺癌多药耐药细胞MCF-7/ADR凋亡的作用并探讨其机制。方法采用脂质体介导法将真核表达载体pEGFP-C1-PTEN及突变载体pEGFP-C1-PTEN-C124S转染人乳腺癌多药耐药MCF-7/ADR细胞。MTT法观察细胞对阿霉素的敏感性和耐药倍数,流式细胞技术检测细胞凋亡率,Western blot检测Bcl-2和Caspase-3蛋白。结果转染组的凋亡率为36.86%,高于对照组(3.75%)和C124S组(4.00%)(P均<0.05)。转染组对阿霉素的耐药倍数显著降低(t=4.77,P<0.05),其半数致死剂量IC50值为对照组的26.1%。转染后细胞内Bcl-2表达降低,且检测到Caspase-3活性裂解片段。结论PTEN基因可能通过下调Bcl-2表达及活化Caspase-3来促进乳腺癌多药耐药MCF-7/ADR细胞凋亡,增加其对阿霉素的药敏性。 Objective To investigate the enhancement effect and mechanism of PTEN on apoptosis induced by adrimytin in breast cancer MCF-7/ADR cell. Methods The eukaryotie expression plasmid pEGFP-CI-PTEN containing whole cDNA of PTEN and its mutation type pEGFP-C1-PTEN-G124S were transfected into MCF-7/ADR cells by Lipofectamine 2000. The apoptosis rate of the cells were observed by flow cytometry. The effect of PTEN on drug chemosensitivity of adrimycin was assessed by MTT tests. The expression of Bel-2 and Caspase-3 were detected by Western blot. Results PTEN overexpression lead to apoptosis of MCF-7/ADR cells (36.86%) detected by flow cytometry, which was much higher than control(3.75% ) and C12S(4.00% ). The multidrug resistant multiple of the cells with PTEN was also much lower than control(P 〈0.05). The expression of Bcl-2 transfected with PTEN was significantly decreased and was detected the 17kd active segment of Caspase-3. Conclusion Overexpression of PTEN induces apoptosis through downregulation of Bcl-2 and active caspase3 in human breast cancer MCF-7/ADR ceils.
出处 《山东医药》 CAS 北大核心 2009年第38期19-20,共2页 Shandong Medical Journal
基金 山东省科学技术发展计划项目(2007GG30002024)
关键词 乳腺肿瘤 乳腺癌 第十号染色体缺失性磷酸酶—张力蛋白基因 细胞凋亡 BCL-2蛋白 CASPASE-3蛋白 breast neoplasm breast cacinoma PTEN gene apoptosis Bcl-2 protein Caspase-3 protein
  • 相关文献

参考文献1

二级参考文献8

  • 1Marchetti S, Mazzanti R, Beijnen JH, et al. Concise review: clinical relevance of drug-drug and herb-drug interactions mediated by the ABC transporter ABCB1 (MDR1 ,P-glycoprotein) [J]. Oncologist, 2007,12(8):927-941.
  • 2Fujita T, Washio K, Takabatake D, et al. Proteasome inhibitors can alter the signaling pathways and attenuate the P- glycoprotein-mediated multidrug resistance [J]. Int J Cancer, 2005,117 (4) : 670-682.
  • 3Shinoda C, Mamyama M, Fujishita T, et al. Doxombicin induces expression of multidrug resistance-associated protein 1 in human small ceU lung cancer cell lines by the c-jan N- terminal kinase pathway [ J ]. Int J Cancer, 2005,117 ( 1 ) : 21- 31.
  • 4Lee JT Jr, Steelman LS, McCubrey JA. Phosphatidylinositol 3' -kinase activation leads to muhidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells [J]. Cancer Res, 2004,64 (22):8397- 8404.
  • 5Choi BH, Kim CG, Lim Y, et al. Curcumin down-regulates the muhidrug-resistance mdrlb gene by inhibiting the PI3-K/ Akt/NF kappa B pathway [J]. Cancer Lett, 2008,259(1): 111-118.
  • 6Qu x, Liu Y, Ma Y, et al. Up-regulation of the Cbl family of ubiquitin ligases is involved in ATRA and bufalin-induced cell adhesion but not cell differentiation [J]. Biochem Biophys Res Co mmun, 2008,367( 1 ) : 183-189.
  • 7Barancik M, Bohacova V, Sedlak J, et al. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P- glycoprotein-mediated multidrug resistance [J ]. Eur J Pharm Sci, 2006,29(5) :426-434.
  • 8石小燕,蔡晓军,类建翔,曹凤军,潘东风,陈萍.PI-3K/Akt抑制剂LY294002对卵巢癌细胞A2780/Taxol多药耐药性的逆转作用[J].癌症,2008,27(4):343-347. 被引量:15

共引文献7

同被引文献11

  • 1Mandard Am,Denoux Y,Herlin P.Prognostic Value of DNA Cytometry in 281 Premenopausal Patients with lymph node negative breast carcinoma randomized in a Control trial. Cancer . 2000
  • 2Clark AS,West K,Streicher S, et al.Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Molecular Cancer . 2002
  • 3Shi W,Zhang X,Pintilie M,et al.Dysregulated PTEN-PKB and negative receptor status in human breast cancer. International Journal of Cancer . 2003
  • 4Zhou X P,Gimm O,Hampel H,et al.Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. American Journal of Pathology . 2000
  • 5Shi W,Zhang X,Pintilie M,et al.Dysregulated PTEN-PKB and negative receptor status in human breast cancer. International Journal of Cancer . 2003
  • 6Andre F,Nahta R,Conforti R, et al.Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer. Annals of Oncology . 2008
  • 7Bose S,Chandran S,Mirocha JM,et al.The Akt pathway in human breast cancer:a tissue-array-based analysis. Modern Pathology . 2006
  • 8Chiarini F,Del Sole M,Mongiorgi S,et al.The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. Leukemia . 2008
  • 9Han Z,Hong L,Han Y,et al.Phospho Akt mediates multidrug resistance of gastric cancer cells through regulation of P-gp, Bcl-2 and Bax. Journal of Experimental and Clinical Cancer Research . 2007
  • 10Perez-Tenorio GA,lkhori H,Oisson B,et al.PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer. Clinical Cancer Research . 2007

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部